Reig Jofre Group   Report issue

For profit Phase 1 Phase 3
Founded: Barcelona Spain (1929)
Status: No NME R&D (1929)

Organization Overview

First Clinical Trial
2009
NCT02071589
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Reig Jofre Group

Active Ingredients

Drugs in Phase 3 Trials (1)

mupirocin (bactroban) (1 trial)

Drugs in Phase 1 Trials (2)

budesonide (rhinocort) (1 trial)

nifedipine (procardia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Impetigo (Phase 3)

Respiratory Aspiration (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3